Clinical Trials Sponsored by Grupo Pulso

Total 675 results

Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax (ENABLE)

Acute Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients

Chronic Lymphocytic Leukemia | CLL

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Hematologic Malignancies

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse

Acute Lymphoblastic Leukemia, in Relapse | Philadelphia-Positive ALL

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches

Acute Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Not yet recruiting

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY). (PROPHECY)

Myeloproliferative Neoplasm
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide (CLL1818)

Chronic Lymphoid Leukemia | Large-B-cell Diffuse Lymphoma

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia (ALL2418)

Acute Lymphoid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia (V-FIRST)

Acute Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia (LLC1114)

Adult Patients | Chronic Lymphocyte Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia | Complete Hematologic Remission (CHR) | Persistent/Recurrent Minimal Residual Disease (MRD)

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Terminated

Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML) (AML1617)

Acute Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Terminated

Retrospective Evaluation of CML Patients in the National Compassionate Program

Chronic Myeloid Leukemia | Philadelphia Positive

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib (CML0609)

Chronic Myeloid Leukaemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients (LAL1104)

Leukemia, Lymphoblastic, Acute

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy (APL0511)

Pregnancy | Acute Promyelocytic Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Covid19 | Hematological Malignancy

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib (LLC1618)

Chronic Lymphocytic Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase (CML0912)

Chronic Phase Philadelphia Positive | BCR-ABL Positive | Chronic Myeloid Leukaemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia

AML, Adult

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML0408)

Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate (LAL1913)

Secondary | De Novo | Untreated Philadelphia Positive Acute Lymphoblastic Leukemia | Low-dose Corticosteroids Pretreatment

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. (ITP0511)

Thrombocytopenia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia. (CLL0911)

B-cell Lymphoid Leukemia | Young Patients

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Unknown

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Germany, Italy, Austria, Iraq, United States, Brazil, China, Malaysia, Netherlands
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia (LAL0904)

Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults (LAL1610)

Acute Lymphoblastic Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

GIMEMA CLL0809 Study (BendOfa) (BendOfa)

Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Unknown

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Immune Thrombocytopenia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Nilotinib in PH+, BCR-, ABL+ CML Patients (CML0811)

Chronic Myeloid Leukemia

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Lymphoma | Multiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Hematologic Neoplasm

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET). (CRICKET)

Metastatic Colorectal Cancer

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Unknown

AML Treatment in Untreated Adult Patients (LAM99P)

Leukemia, Myelocytic, Acute

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease (CAD0111)

Refractory Cold Agglutinin Disease

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura (ITP0207)

Nonneoplastic Condition

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Myelodysplastic Syndromes | Hemosiderosis

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Terminated

Velcade in Myelodysplastic Syndrome - Pilot Study

MDS

Italy
Gruppo Oncologico del Nord-Ovest

Completed

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

Colorectal Cancer Metastatic
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Italy
Grupo Argentino de Tratamiento de la Leucemia Aguda

Recruiting

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

Acute Lymphoblastic Leukemia, Adult

Argentina
Grupo de Investigación Clínica en Oncología Radioterapia
Norgine

Recruiting

Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients

Acute Esophagitis

Spain
Grupo Argentino de Tratamiento de la Leucemia Aguda

Completed

Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia

AML | Pediatric AML
Pragmatech AI Solutions
NAMSA; Grupo Hospital de Madrid

Completed

Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment (EVIAST)

Bacterial Infections

Spain
Grupo Español de Investigación en Cáncer de Ovario

Completed

Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD

Ovarian Cancer

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT (BUFLU)

Acute Myeloid Leukemia | Myeloproliferative Disorders | Chronic Myeloid Leukemia | Myelodysplastic Syndrome
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia (DASA-TRAS)

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Spain
Grupo Español de Investigación en Cáncer de Ovario

Completed

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

Spain
Grupo de Investigação em Bioquímica e Biologia...

Completed

Comparison of Visual and Spectrophotometric Methods for Dental Color Measurement - An in Vivo Study

Tooth | Color Perception
Grupo Español de Investigación en Cáncer de Ovario

Completed

Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer

Platinum-resistant Advanced Ovarian Cancer

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. (CSM/EICH2010)

Chronic Graft-Versus-Host Disease

Spain

Clinical Trials Sponsored by Grupo Pulso

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations